Sunil Healthcare (BOM:537253) Net Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:537253 Sunil Healthcare Ltd BOM:537253
59 GF Score
Price ₹73.64
GF Value ₹68.23
Valuation Fairly Valued
! 9 Warning Signs
View Full Analysis

What is Sunil Healthcare Net Loan?

Net Loan only applies to banks and insurance companies.

BOM:537253
59GF Score
Sunil Healthcare Ltd BOM:537253
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sunil Healthcare (BOM:537253) Overvalued in 2026?

Based on GuruFocus' analysis, Sunil Healthcare stock appears to be overvalued. The current stock price of ₹73.64 is trading 7.9% above its estimated GF Value™ of ₹68.23. GuruFocus considers Sunil Healthcare to be Fairly Valued.

Key valuation signals for BOM:537253:

  • Net Loan:
  • GF Value™: ₹68.23 vs. price of ₹73.64 (7.9% above fair value)
  • GF Score™: 59/100 with 9 warning signs

No single metric tells the full story. See the BOM:537253 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sunil Healthcare Business Description

Other Exchanges SUNLOC:India
Address 38E/252 - A, Vijay Tower, 3rd Floor, Opposite Panchsheel Commercial Complex, Shahpurjat, New Delhi, IND, 110049
Sunil Healthcare Ltd is an Indian manufacturer of empty hard gelatin capsule shells, which are sold to pharmaceutical companies, nutraceutical and food supplement makers, and contract manufacturers for use in encapsulating powders, pellets, granules, and liquids. The company operates in a single business segment, Empty Capsules, and produces capsules in a range of standard sizes along with specialty formats such as preservative-free, BSE-free, pearl, liquid-fill, and stick-free capsules. Its customers are primarily drug and supplement producers that require capsule shells as an input for their finished dosage forms. Revenue is generated through the sale of capsule shells, with the majority of sales coming from the domestic Indian market and the remainder from exports to international pharmaceutical and nutraceutical customers. The business depends on volume-driven orders from formulators and consistent demand from the pharmaceutical and health supplement industries.
59GF Score

Get the complete analysis for BOM:537253

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹73.64
Price
₹68.23
GF Value